Pharming Group Nv

Pharming Group announces the 2026 Annual General Meeting of Shareholders

Pharming Group to participate in April investor conferences

Pharming Group announces the filing of its 2025 Annual Report and Form 20-F

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older